Astrazeneca's New COVID Antibody Drug Provides Instant Coronavirus Immunity, May Be Available on March Scientists are studying the possibility of providing instant long-term immunity to patients who are at higher risk using the new COVID antibody drug developed by Astrazeneca. by CJ Robles
EU Data Protection Task Force Examines OpenAI's ChatGPT Privacy Compliance, Reveals Preliminary Findings